Another LaunchPad Fellow, Dr. Yaw Ansong Jr., from the University of California, Berkeley, and his co-founder, Timothy Adamson, a student at Yale, were also compelled to pursue a medical startup in response to a healthcare challenge they observed firsthand.
Sickle cell anemia, prevalent in many Black and Hispanic populations, remains frustratingly expensive to fully diagnose and treat. (Many patients with sickle cell spend as much as $1 million dollars in total healthcare costs by the age of 45 years.) As a physician who has seen patients unable to afford the needed diagnostic testing, and as a carrier of the trait himself, Yaw was compelled to take action.
In response, these two young founders started KovaDx, a company developing a faster, cheaper, and easier method to diagnose and monitor sickle cell via a device and accompanying AI platform. (The name of the company was derived from Timothy’s Estonian heritage: “Kova” means strength or resilience, and the “Dx” stands for diagnostics.)… Read more here.